The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

Bioassays: Scientific Approaches & Regulatory Strategies is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays.

The goal of the CE Pharm Symposium is to provide a forum for the discussion of recent developments in CE analysis of protein, nucleotide and small molecule pharmaceuticals. The presentations and workshops will be devoted completely to practical concerns to strengthen the use of CE within the biotechnology and pharmaceutical industries.

The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.

The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.

We are pleased to welcome you back to the in-person CMC Strategy Forum Japan. The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific. The Forum strives to share information with the regulatory agencies to assist them in merging good scientific and regulatory practices.

The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

The WCBP Symposium series has established a reputation as the most highly-regarded annual conference addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.

Analytical Technologies Europe: Symposium on Analytical Sciences and Regulatory Trends in the Biopharmaceutical Industry provides an active forum for the discussion of recent developments, regulatory considerations, and practical applications of analytical technologies in the biopharmaceutical industry.

The Cell and Gene Therapy Products Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.